Modern Monetary Theory (MMT): from theory to practice

Virus still spreading. First, the sanitary situation: still worrying. The total numbers of recorded Covid-19 cases is now over half a million, and the number of deaths close to 25k.
  • Market Commentaries

Virus still spreading. First, the sanitary situation: still worrying. The total numbers of recorded Covid-19 cases is now over half a million, and the number of deaths close to 25k. Contagion from east to west continues, with the US now the center of attention: the country has more reported cases than China.

The total number of cases (world) has grown at an average daily pace of 13% in the week to 26 March, 5 points faster than the previous week. One bit of positive news, however: confinement measures seem to be working, with the number of cases in Italy now growing at less than 8% per day, down from about 15% just a week ago.

The United States are about 15-20 days behind Italy, so there is hope that in a couple of weeks percentage growth will also start to slow there. This is not for sure: social distancing in the US does not seem as severe.

COVID-19 UPDATE: Facts & Figures 16/10/2020
Download
PDF
MORE INSIGHTS

RELATED INSIGHTS

READ NOW
CHINA’S RECOVERY CONTINUED BUT A BIT SOFTER THAN EXPECTED
China's economic recovery continued in Q3 2020, although a bit softer than expected. Real GDP growth rose to 4.9% yoy, slightly below the Reuters consensus expectation of 5.2% yoy, but still a substantial upturn from the 3.2% yoy in Q2. On a quarterly base, growth dynamics softened to 2.7% qoq, after 11.7% qoq and -10% qoq in the two previous quarters.
READ NOW
Citywire video-interview with Peter Marber
Watch Peter Marber, fund manager of this global, non-directional, long/short approach to Emerging Markets debt, in a video-interview by Citywire.
READ NOW
COVID-19 FACTS & FIGURES
According to the IMF’s Managing Director, strong international cooperation on coronavirus vaccine could speed up the world economic recovery and add $9 trillion to global income by 2025. A WHO trial found that Remdesivir, Hydroxychloroquine, Lopinavir and Interferon have little or no effect on hospitalized Covid-19 patients. Gilead Sciences has questioned the findings of the WHO study saying data appeared inconsistent.
MORE INSIGHTS